Stephen J. Schueler, M.D.

Overview Incidence Risk Factors Symptoms Evaluation Treatment questions for doctor specialist Home Care diet warning signs Prevention Outlook Complications Underlying Cause Transmission Types Anatomy

Hepatitis from a Virus Questions For Doctor

The following are some important questions to ask before and after the treatment of viral hepatitis.

Questions to ask before treatment:

  • What are my treatment options?
  • What are the risks associated with treatment?
  • Do I need to stay in the hospital?
    • How long will I be in the hospital?
  • Am I contagious?
    • For how long?
  • What are the complications I should watch for?
  • How do I avoid passing the infection to others?
  • How long will I be on medication?
  • What are the potential side effects of my medication?
  • Does my medication interact with nonprescription medicines or supplements?
  • Should I take my medication with food?

Questions to ask after treatment:
  • Do I need to change my diet?
  • Are there any medications or supplements I should avoid?
  • When can I resume my normal activities?
  • When can I return to work?
  • What else can I do to reduce my risk for complications of viral hepatitis?
  • How often will I need to see my doctor for checkups?
  • What local support and other resources are available?

Continue to Hepatitis from a Virus Specialist

Last Updated: Jul 15, 2009 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor

PubMed Hepatitis from a Virus References
  1. Bianco E, De Masi S, Mele A, Jefferson T. Effectiveness of immune globulins in preventing infectious hepatitis and hepatitis A: a systematic review. Dig Liver Dis. 2004 Dec;36(12):834-42. [1564643]
  2. Ferenci P. Treatment of chronic viral hepatitis. Best Pract Res Clin Gastroenterol. 2004;18 Suppl:113-20. [15588803]
  3. Kanwal F, Gralnek IM, Martin P, Dulai GS, Farid M, Spiegel BM. Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis. Ann Intern Med. 2005 May 17;142(10):821-31. [1589753]
  4. Kim AI, Saab S. Treatment of hepatitis C. Am J Med. 2005 Aug;118(8):808-15. [16084169]
  5. Oncu S, Oncu S, Sakarya S. Hepatitis A and B seropositivity among medical students. Health Policy. 2005 Sep 28;74(1):39-45. [16098410]
  6. Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA. 2005 Jul 13;294(2):194-201. [1601459]
FreeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.